Full-Time

Digital Gbus Transformation and Value Realization lead

Posted on 10/25/2024

Sanofi

Sanofi

10,001+ employees

Develops pharmaceuticals and life-saving vaccines

Biotechnology
Healthcare

Senior, Expert

Cambridge, MA, USA

Onsite presence required.

Category
Project Management
Strategy Development
Business & Strategy
Required Skills
Business Strategy
Data Analysis
Requirements
  • 10 years of professional experience especially with experience at a top strategic consulting firm
  • Solid industry background and understanding & process a strong business acumen (proven leadership experience in both commercial and digital roles with a focus on commercial)
  • Seasoned leader with outstanding communication and presentation skills.
  • Proven record of creating and implementing successful digital business strategies.
  • Very strong problem-solving skills and analytical capabilities
  • Very strong project management and execution skills
  • Ability to cultivate effective relationships, and to influence and collaborate internally and externally at all organizational levels.
  • Exceptional communication and influencing skills to effectively engage stakeholders at all levels.
  • Team player with great interpersonal skills, positive attitude, and confident demeanor.
  • A passion for innovation, problem-solving, and driving business transformation.
Responsibilities
  • Lead Quarterly Value Releases (QVR) process Cadenced process jointly with business including 90-day cycle value target setting and delivery and and provide holistic approach to product and value delivery, from end-to-end delivery of digital, analytics, tech components to revision of business processes to ensure easy product adoption and change management
  • Lead Transformation and Value Realization Office (TVRO) as X-functional and x-GBU body fostering value-driven decision making, prioritize resource allocation to new initiatives, resolve cross-GBU tradeoffs, as escalated by TVRO, Review value and product delivery targets and realization
  • Consolidates and validates blueprints across products
  • Synthetizes value targets and value realization
  • Escalates prioritization / x-GBU tradeoffs decisions to DAB
  • Acts as a spider in the web to coordinate technical feedback to POs on roadmap and blueprint, based on inputs collected from relevant SMEs
  • Validate individual product roadmap and quarterly blueprints submitted by POs and BOs
  • Validate allocation of resources for new products and suggest reallocation of resources across products (based on historical progresses, strategic priorities, expected returns of investments…)
  • Inform DAB of quarterly blueprint for individual products
  • Present relevant demos to DAB (jointly with relevant POs)
  • Escalate resolution of x-GBU tradeoffs to DAB
  • Own KPI framework, control tower, and change mgmt. framework

Sanofi provides healthcare solutions through its pharmaceutical and biotechnology products, focusing on treatments and vaccines for various medical needs. The company conducts extensive research and development to create new therapies and improve existing ones, particularly in areas like immunology, oncology, and rare diseases. Sanofi's products include prescription medicines, over-the-counter items, and vaccines, which are distributed to patients, healthcare professionals, and governments. What sets Sanofi apart from its competitors is its strong emphasis on scientific innovation and strategic partnerships, allowing it to maintain a diverse pipeline of products. The company's goal is to enhance health outcomes and improve the quality of life for people globally.

Company Stage

IPO

Total Funding

$2B

Headquarters

Paris, France

Founded

1973

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Simplify Jobs

Simplify's Take

What believers are saying

  • Sanofi's AI tool Muse accelerates patient recruitment in clinical trials.
  • Dupixent's EU approval expands Sanofi's pediatric treatment market.
  • BrightInsight partnership enhances digital health solutions for better patient outcomes.

What critics are saying

  • Increased competition in the rare disease sector from biotech startups.
  • Regulatory risks due to liver enzyme elevations in tolebrutinib trials.
  • Dependence on strategic partnerships like BrightInsight for digital health initiatives.

What makes Sanofi unique

  • Sanofi's Care4Rare program supports innovative solutions for rare diseases.
  • The MyWay app enhances patient engagement and medication adherence.
  • Tolebrutinib is the first brain-penetrant BTK inhibitor for multiple sclerosis.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE